Search

everythinglearnresearchcommunity

for

Search:↓

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

PRP injections may slightly improve hair density and count for male hair loss, but more research is needed.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

New-onset fibromyalgia after COVID-19 is poorly understood, needing better definitions and studies.

People today have lower levels of arsenic, lead, cadmium, and iron in their hair than people did 100 years ago.

Collider bias can distort our understanding of COVID-19 risk and severity.

Hair analysis can detect cocaine use but doesn't accurately show the amount or timing of use.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Most people on isotretinoin had chapped lips, but only a few stopped the medicine due to side effects.

Older age and existing health conditions increase COVID-19 death risk.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Finasteride improves chronic pelvic pain, saw palmetto doesn't.

A new gene, JMJD1C, may affect testosterone levels in men.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Modified rat stem cells on a special scaffold improved blood vessel formation and wound healing in skin substitutes.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Finasteride effectively increases hair growth in men with AGA, works better for those over 30, and may cause some side effects.

All three shampoos reduced dandruff and hair loss, but ketoconazole and piroctone olamine also made hair thicker.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.